930 related articles for article (PubMed ID: 8900375)
1. Expression of MAGE-1, MAGE-3 and MART-1 genes in neuroblastoma.
Corrias MV; Scaruffi P; Occhino M; De Bernardi B; Tonini GP; Pistoia V
Int J Cancer; 1996 Oct; 69(5):403-7. PubMed ID: 8900375
[TBL] [Abstract][Full Text] [Related]
2. MAGE-1 and MAGE-3 or -6 expression in neuroblastoma-related pediatric solid tumors.
Ishida H; Matsumura T; Salgaller ML; Ohmizono Y; Kadono Y; Sawada T
Int J Cancer; 1996 Oct; 69(5):375-80. PubMed ID: 8900370
[TBL] [Abstract][Full Text] [Related]
3. Expression of the MAGE-1 tumor antigen is up-regulated by the demethylating agent 5-aza-2'-deoxycytidine.
Weber J; Salgaller M; Samid D; Johnson B; Herlyn M; Lassam N; Treisman J; Rosenberg SA
Cancer Res; 1994 Apr; 54(7):1766-71. PubMed ID: 7511051
[TBL] [Abstract][Full Text] [Related]
4. MAGE-A1 expression is associated with good prognosis in neuroblastoma tumors.
Grau E; Oltra S; Martínez F; Orellana C; Cañete A; Fernández JM; Hernández-Martí M; Castel V
J Cancer Res Clin Oncol; 2009 Apr; 135(4):523-31. PubMed ID: 18820946
[TBL] [Abstract][Full Text] [Related]
5. The cancer germ-line genes MAGE-1, MAGE-3 and PRAME are commonly expressed by human myeloma cells.
Pellat-Deceunynck C; Mellerin MP; Labarrière N; Jego G; Moreau-Aubry A; Harousseau JL; Jotereau F; Bataille R
Eur J Immunol; 2000 Mar; 30(3):803-9. PubMed ID: 10741395
[TBL] [Abstract][Full Text] [Related]
6. Detection of microscopic disease: comparing histology, immunocytology, and RT-PCR of tyrosine hydroxylase, GAGE, and MAGE.
Cheung IY; Cheung NK
Med Pediatr Oncol; 2001 Jan; 36(1):210-2. PubMed ID: 11464887
[TBL] [Abstract][Full Text] [Related]
7. Expression and clinical relevance of NY-ESO-1, MAGE-1 and MAGE-3 in neuroblastoma.
Söling A; Schurr P; Berthold F
Anticancer Res; 1999; 19(3B):2205-9. PubMed ID: 10472332
[TBL] [Abstract][Full Text] [Related]
8. HER-2, gp100, and MAGE-1 are expressed in human glioblastoma and recognized by cytotoxic T cells.
Liu G; Ying H; Zeng G; Wheeler CJ; Black KL; Yu JS
Cancer Res; 2004 Jul; 64(14):4980-6. PubMed ID: 15256472
[TBL] [Abstract][Full Text] [Related]
9. Expression of the MAGE gene family in human gastric carcinoma.
Li J; Yang Y; Fujie T; Tanaka F; Mimori K; Haraguchi M; Ueo H; Mori M; Akiyoshi T
Anticancer Res; 1997; 17(5A):3559-63. PubMed ID: 9413202
[TBL] [Abstract][Full Text] [Related]
10. Infrequent expression of the MAGE gene family in uveal melanomas.
Mulcahy KA; Rimoldi D; Brasseur F; Rodgers S; Liénard D; Marchand M; Rennie IG; Murray AK; McIntyre CA; Platts KE; Leyvraz S; Boon T; Rees RC
Int J Cancer; 1996 Jun; 66(6):738-42. PubMed ID: 8647642
[TBL] [Abstract][Full Text] [Related]
11. Detection of naturally processed and HLA-A1-presented melanoma T-cell epitopes defined by CD8(+) T-cells' release of granulocyte-macrophage colony-stimulating factor but not by cytolysis.
Maeurer MJ; Martin D; Elder E; Storkus WJ; Lotze MT
Clin Cancer Res; 1996 Jan; 2(1):87-95. PubMed ID: 9816095
[TBL] [Abstract][Full Text] [Related]
12. MAGE-12 and MAGE-6 are frequently expressed in malignant melanoma.
Gibbs P; Hutchins AM; Dorian KT; Vaughan HA; Davis ID; Silvapulle M; Cebon JS
Melanoma Res; 2000 Jun; 10(3):259-64. PubMed ID: 10890380
[TBL] [Abstract][Full Text] [Related]
13. Analysis of MAGE-3-specific cytolytic T lymphocytes in human leukocyte antigen-A2 melanoma patients.
Valmori D; Liénard D; Waanders G; Rimoldi D; Cerottini JC; Romero P
Cancer Res; 1997 Feb; 57(4):735-41. PubMed ID: 9044853
[TBL] [Abstract][Full Text] [Related]
14. MAGE-B5, MAGE-B6, MAGE-C2, and MAGE-C3: four new members of the MAGE family with tumor-specific expression.
Lucas S; De Plaen E; Boon T
Int J Cancer; 2000 Jul; 87(1):55-60. PubMed ID: 10861452
[TBL] [Abstract][Full Text] [Related]
15. Combined use of oligonucleotide and tissue microarrays identifies cancer/testis antigens as biomarkers in lung carcinoma.
Sugita M; Geraci M; Gao B; Powell RL; Hirsch FR; Johnson G; Lapadat R; Gabrielson E; Bremnes R; Bunn PA; Franklin WA
Cancer Res; 2002 Jul; 62(14):3971-9. PubMed ID: 12124329
[TBL] [Abstract][Full Text] [Related]
16. Differential MAGE-1 gene expression in two variants of an erythroleukemic cell line (K562).
Serrano A; Garcia A; Abril E; Garrido F; Ruiz-Cabello F
Immunobiology; 1995 Nov; 194(4-5):449-56. PubMed ID: 8749237
[TBL] [Abstract][Full Text] [Related]
17. Expression of cancer-testis antigen (CTA) genes in intrahepatic cholangiocarcinoma.
Utsunomiya T; Inoue H; Tanaka F; Yamaguchi H; Ohta M; Okamoto M; Mimori K; Mori M
Ann Surg Oncol; 2004 Oct; 11(10):934-40. PubMed ID: 15466353
[TBL] [Abstract][Full Text] [Related]
18. [Expression of tumor-specific cancer/testis antigens in hepatocellular carcinoma].
Chen HS; Qin LL; Cong X; Wang Y; Fei R; Jiang D; Cao J; Su JJ; Wei L; Chen WF; Wang Y
Zhonghua Gan Zang Bing Za Zhi; 2003 Mar; 11(3):145-8. PubMed ID: 12681059
[TBL] [Abstract][Full Text] [Related]
19. A peptide encoded by human gene MAGE-3 and presented by HLA-A2 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE-3.
van der Bruggen P; Bastin J; Gajewski T; Coulie PG; Boël P; De Smet C; Traversari C; Townsend A; Boon T
Eur J Immunol; 1994 Dec; 24(12):3038-43. PubMed ID: 7805731
[TBL] [Abstract][Full Text] [Related]
20. Expression of MAGE genes in primary and metastatic cutaneous melanoma.
Brasseur F; Rimoldi D; Liénard D; Lethé B; Carrel S; Arienti F; Suter L; Vanwijck R; Bourlond A; Humblet Y
Int J Cancer; 1995 Nov; 63(3):375-80. PubMed ID: 7591235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
